Team: Global Market Access and Pricing – Obesity& Access, Product & Portfolio Strategy
As Senior Global Pricing Lead, you will set the pricing direction for assets in your therapy area(s), from early development through launch. You will turn clinical innovation into a clear pricing rationale and give leadership the insight to make sharper decisions on development, investment and launch sequence. Working globally, you will help make sure pricing reflects the value of our treatments and supports access for people living with serious chronic diseases.
You will own pricing for your therapy area(s) end to end, from strategy and insights to the operational detail of launch. In practice, that means:
You will join Global Market Access and Pricing – Obesity& Access, part of Product & Portfolio Strategy. In Product & Portfolio Strategy, colleagues connect commercial strategy, medical affairs and business development across therapy areas. Our team defines, shapes and operationalises payer-relevant value and access strategies across the asset lifecycle, working where science, evidence and health systems meet.
Your closest partners will be market access and commercial colleagues, the Portfolio Strategy Unit, Business Development, Finance and PSIA, alongside HEOR, Payer Evidence, Clinical Development and Medical. You will work with NAO/IO pricing and access teams and regional and strategic market teams, and agree pricing strategies and PBCs with senior leaders up to EVP level. Externally, you will work with vendors and may present at conferences.
Your scope is global. You will act within the Pricing Procedure SOP and other key processes, and your manager can grant further responsibilities.
You will work where your expertise shapes decisions that matter, from early development to launch, and build new skills by working with colleagues across the value chain.
You will be supported to perform at your best, and trusted to own your decisions, make your voice heard and follow through. The work moves at pace, and you will be part of a team that combines curiosity, collaboration and ambition to create progress.
Your impact begins today. If you are ready to turn clinical innovation into pricing that supports access for people around the world, apply for the Senior Global Pricing Lead role by 10 November 2026. Applications are reviewed on an ongoing basis, so we encourage you to apply as soon as possible.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html